| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,088 |
35,365 |
$4.81M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,659 |
13,104 |
$4.76M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
13,528 |
9,140 |
$1.94M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,735 |
12,538 |
$1.71M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,958 |
1,916 |
$507K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,335 |
2,731 |
$399K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,765 |
1,748 |
$244K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,406 |
1,344 |
$190K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,878 |
1,633 |
$161K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
8,299 |
6,146 |
$108K |
| 87400 |
|
6,436 |
6,276 |
$92K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,203 |
5,125 |
$72K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
325 |
320 |
$62K |
| 85027 |
|
11,711 |
10,769 |
$52K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,588 |
2,490 |
$50K |
| 87486 |
|
1,959 |
1,917 |
$44K |
| 87581 |
|
1,958 |
1,916 |
$44K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,959 |
1,917 |
$42K |
| 87430 |
|
3,559 |
3,489 |
$34K |
| 76825 |
|
145 |
139 |
$34K |
| 80053 |
Comprehensive metabolic panel |
4,205 |
3,775 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
1,335 |
1,302 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,898 |
1,736 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,258 |
1,232 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,355 |
956 |
$22K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,117 |
2,015 |
$21K |
| 87070 |
|
2,385 |
2,337 |
$18K |
| 81001 |
|
7,390 |
7,166 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,730 |
2,684 |
$13K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
179 |
172 |
$13K |
| 76801 |
|
106 |
95 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,117 |
1,980 |
$9K |
| 76821 |
|
128 |
60 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,052 |
1,005 |
$8K |
| 76820 |
|
119 |
52 |
$7K |
| 93325 |
|
144 |
138 |
$6K |
| 93976 |
|
58 |
51 |
$6K |
| 94644 |
|
80 |
80 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
164 |
163 |
$4K |
| 81025 |
|
960 |
917 |
$4K |
| 87420 |
|
474 |
472 |
$4K |
| 76827 |
|
40 |
39 |
$3K |
| 84702 |
|
220 |
192 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
826 |
755 |
$3K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
587 |
563 |
$2K |
| 83690 |
|
907 |
855 |
$2K |
| 84484 |
|
988 |
656 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$1K |
| 86141 |
|
189 |
185 |
$1K |
| 74018 |
|
26 |
26 |
$447.76 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20 |
13 |
$443.13 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
54 |
53 |
$432.99 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17 |
12 |
$313.20 |
| 86901 |
|
201 |
188 |
$308.73 |
| 86900 |
|
201 |
188 |
$308.73 |
| 84703 |
|
73 |
68 |
$283.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,527 |
1,388 |
$260.85 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
144 |
135 |
$235.53 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
128 |
119 |
$170.01 |
| 83735 |
|
73 |
54 |
$99.81 |
| 87186 |
|
14 |
12 |
$46.99 |
| 82248 |
|
28 |
28 |
$21.92 |
| 85610 |
|
100 |
82 |
$21.60 |
| 85730 |
|
31 |
28 |
$20.20 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
56 |
54 |
$9.85 |
| 84100 |
|
17 |
12 |
$5.39 |
| A9270 |
Non-covered item or service |
2,551 |
1,256 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
26 |
25 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
79 |
65 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
19 |
16 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18 |
12 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
13 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
66 |
39 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
174 |
169 |
$0.00 |